Arch Therapeutics, Inc. insider trading activity
Understanding Insider Activity at Arch Therapeutics, Inc.
Welcome to our dedicated page for Arch Therapeutics, Inc. (OTC: ARTH) insider trading activity, sourced directly from the SEC Form 4 Filings. Here, you'll find the latest buying and selling activities undertaken by Arch Therapeutics, Inc.'s key insiders, providing a unique window into the company's internal sentiments.
How to Use This Data:
Below, you can view insider transactions that were reported to the SEC within the last 365 days.
While insider trading can hint at a company's prospects, it's crucial to approach this data as part of a broader investment strategy. Look for patterns over time, significant buys or sells, and consider other market factors before making investment decisions.
Scroll down to view the most recent insider transactions for Arch Therapeutics, Inc., and gain a better understanding of the confidence and considerations of those intimately tied to the company's success.
Track insider trades for ARTH| Ticker | Time & Date | Filing | Link |
|---|---|---|---|
| ARTH | 9:47:59 PM, 9/8/2023 | ABRAMS MICHAEL S(CHIEF FINANCIAL OFFICER) purchased 10292 shares of Arch Therapeutics, Inc. (ARTH) for ~$2881 | Filing |
| ARTH | 9:47:40 PM, 9/8/2023 | Norchi Terrence W(PRESIDENT AND CHIEF EXECUTIVE) purchased 6862 shares of Arch Therapeutics, Inc. (ARTH) for ~$1921 | Filing |
| ARTH | 9:47:19 PM, 9/8/2023 | Hicks Laurence purchased 10292 shares of Arch Therapeutics, Inc. (ARTH) for ~$2881 | Filing |